Zacks.com on MSN
Ingersoll Rand (IR) Surpasses Q4 Earnings and Revenue Estimates
Ingersoll Rand (IR) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.84 per share a year ago. These figures ...
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results